Clinical trial
Tracking Renal Tumors After Cryoablation Evaluation (TRACE) Registry
NCT01117779 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tracking Renal Tumors After Cryoablation Evaluation (TRACE) Registry
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Observational
- Overall status
- Terminated
- Start date
- July 9, 2010
- Completion date
- November 24, 2020
- Enrollment
- 246 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.